BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 17, 2014
View Archived Issues
Mymetics to manufacture Imugene's HER-Vaxx cancer immunotherapy
Read More
Medigene completes capital increase to fund cancer immunotherapy programs
Read More
Immatics biotechnologies receives final tranche of series D financing
Read More
C2N expands partnership with WUSM for Alzheimer's blood test
Read More
La Jolla Pharmaceutical's LJPC-1010 shows promise in preclinical model of NASH
Read More
Lilly discloses new anti-BMP-6 MAbs
Read More
Daiichi Sankyo to begin several trials of DS-5565 for pain associated with fibromyalgia
Read More
Novartis patents new modified IGF-I polypeptides
Read More
New disulfide-linked multivalent multi-function proteins divulged by Roche
Read More
Merck & Co. synthesizes novel glucokinase activators
Read More
Novel gamma-secretase modulators synthesized by Janssen Pharmaceutica
Read More
CSF proteins as potential markers of pediatric CNS tumors
Read More
Novel CFTR channel inhibitors patented by Novartis
Read More
Researchers from Lexicon present promising data for LX-4211 in humans and mice
Read More
Actinium Pharmaceuticals begins development of new actinium-225-labeled antibody construct
Read More
Researchers in France divulge new agents for mycobacterial infections
Read More
FDA lifts partial clinical hold on CTP-354
Read More
SUVN-A60203 counteracts cognitive defects associated with neuropathic pain
Read More
Epirus Biopharmaceuticals and Zalicus complete merger
Read More
Nintedanib receives breakthrough therapy designation for idiopathic pulmonary fibrosis
Read More
InnoPharma acquired by Pfizer
Read More
Isavuconazole receives another QIDP designation from FDA
Read More
BioLineRx reports data from phase I/II study of BL-7010 in celiac disease
Read More
FDA approves Ruconest for acute angioedema attacks
Read More
Lorus Therapeutics proposes name change
Read More
